A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a widespread endocrine disease that affects 6% to 20% of women of reproductive age and is associated with high risk of infertility, obesity, and insulin resistance. Although genetic, neuroendocrine, and metabolic causes have been stated to lead to PCOS, the etiology of PCOS remains unclear. Recent studies in humans and rodent models have shown an association between changes in the gut microbiome and the metabolic and clinical parameters of PCOS. In addition, it has been proposed that dysbiosis of gut microbiota may be a potential pathogenetic factor in the development of PCOS. In this context, modification of gut microbiota with probiotic, prebiotic, and synbiotic agents suggests that these products may serve as new treatment options for PCOS. In this review, it is aimed to explain the relationship between PCOS and gut microbiota with possible mechanisms and to examine the new treatment approaches that can be developed in this direction. Key teaching pointsStudies have shown that gut microbiota may be a potential pathogenetic factor in the development of PCOS.Dysbiosis of gut microbiota in women with PCOS appears to be associated with PCOS phenotypes.Studies suggest that insulin resistance, sex hormone concentrations, and obesity may affect the diversity and composition of gut microbiota in women with PCOS.With better understanding of the role of intestinal microbiota in PCOS, interventions including prebiotics, probiotics, and synbiotics can be considered as future treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“PYY secretion is known to be regulated by the SCFA-producing intestinal microbiota (30).”
BackgroundHotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543 · cited 1×
“The increase in proinflammatory cytokines results in an increase in intestinal permeability and consequently metabolic endotoxemia by reducing tight junction protein production (59).”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241 · cited 1×
“In addition, SCFAs have a strong immunomodulatory effect, leading to the production and release of protective peptides, cytokines, chemokines, and phagocytes (35).”
BackgroundAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121 · cited 1×
“PCOS was first described as a combination of hirsutism, amenorrhea, chronic anovulation, infertility, obesity, and polycystic ovaries by Stein and Leventhal in 1935 (11).”
BackgroundPolycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Research works printed but not linked: 62
- 10.5505/kjms.2017.24582 · DOI
- 10.1056/NEJMra041536 · DOI · Paper page
- 10.5152/jtgga.2012.39 · DOI · Paper page
- 10.3389/fmicb.2017.00324 · DOI · Paper page
- Zawadski JK , Dunaif A . Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A , Givens JR and Haseltine F , editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992, p. 377–384.
- 10.3389/fphys.2016.00124 · DOI · Paper page
- 10.1586/eem.11.85 · DOI
- 10.12809/hkmj176308 · DOI
- 10.1016/j.gtc.2016.09.002 · DOI
- 10.1007/s12020-018-1605-5 · DOI · Paper page
- 10.3389/fcimb.2012.00104 · DOI · Paper page
- 10.2217/fmb.11.142 · DOI · Paper page
- 10.2147/BTT.S19099 · DOI · Paper page
- 10.5543/tkda.2016.72461 · DOI
- 10.1002/dmrr.2518 · DOI · Paper page
- 10.1080/13102818.2018.1481350 · DOI
- 10.1371/journal.pone · doi:10.1371/journal.pone
- Mammadova G . Polikistik over sendromlu ve sağlıklı kadınlarda bağırsak mikrobiyota üyelerinden Prevotella Melaninogenica. Ruminococcus Torques ve Clostridium Difficile karşılaştırılması. [dissertation]. Turkey (TR): Hacettepe University; 2017.
- 10.1080/19490976.2018 · doi:10.1080/19490976.2018
- 10.1016/j.resmic · doi:10.1016/j.resmic
- 10.1128/mSystems.00017-19 · DOI · Paper page
- 10.1038/nrgastro.2016.4 · DOI · Paper page
- 10.2337/db06-1491 · DOI · Paper page
- 10.1530/EC-15-0094 · DOI · Paper page
- 10.3164/jcbn.15-152 · DOI · Paper page
- 10.1093/jn/125.6.1401 · DOI · Paper page
- 10.3389/fmicb.2016.00925 · DOI · Paper page
- 10.2337/db14-1847 · DOI · Paper page
- 10.1016/j.chom.2013.08.006 · DOI · Paper page
- 10.1038/nri1937 · DOI · Paper page
- 10.1210/jcem.87.8.8715 · doi:10.1210/jcem.87.8.8715 · Paper page
- 10.1210/jcem.87.3.8309 · DOI · Paper page
- Kuzu F . Bağırsak Mikrobiyotasının Obezite. İnsülin Direnci ve Diyabetteki Rolü. BSHR. 2017;1:68–80.
- Saka M . Obezite-Mikrobiyota İlişkisi. Turkiye Klinikleri J Nutr. Dietetics. 2016;2(1):79–83.
- 10.1530/EJE-14-0589 · DOI · Paper page
- 10.1017/S0007114510002874 · DOI · Paper page
- 10.1210/endo-123-2-733 · DOI · Paper page
- Evliyaoğlu O . Polycystic ovary syndrome and hirsutism. Turkish Pediatrics Arch. 2011;2(46):8–13.
- 10.1016/s0015-0282(16)55675-1 · DOI · Paper page
- 10.1016/j.ando.2010.02.007 · DOI
- 10.1210/er.2004-0004 · DOI · Paper page
- 10.1016/j.fertnstert.2016.05.011 · DOI
- 10.1016/j.fertnstert.2010.11.036 · DOI · Paper page
- Konturek S , Konturek P , Pawlik T , Brzozowski T . Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol. 2004;55(1 Pt 2):137–154.
- 10.1159/000430229 · DOI · Paper page
- 10.1210/jc.2013-1526 · DOI · Paper page
- 10.1074/jbc.R116.767434 · DOI · Paper page
- 10.4103/2008-7802.153866 · DOI · Paper page
- 10.1080/14647273.2017.1283446 · DOI · Paper page
- 10.1016/j.jff.2017.06.029 · DOI
- 10.1016/j.jff.2017.12.047 · DOI
- Karamali M , Eghbalpour S , Rajabi S , Jamilian M , Bahmani F , Tajabadi-Ebrahimi M , Keneshlou F , Mirhashemi SM , Chamani M , Hashem Gelougerdi S , et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2018;21(1):1–7.
- 10.1007/s00394-018-1648-7 · DOI
- 10.1186/s12902-018-0248-0 · DOI · Paper page
- 10.1007/s12602-018-9405-z · DOI
- 10.1016/j.numecd.2018.07.002 · DOI · Paper page
- Altun HK , Yıldız EA . Prebiyotikler ve Probiyotiklerin Diyabet ile İlişkisi. Turk J Life Sci. 2017;1(2):149–156.
- 10.1007/s12602-018-9493-9 · DOI
- 10.3389/fmicb.2019.00175 · DOI · Paper page
- 10.1016/0016-5085(95)90192-2 · DOI · Paper page
- 10.3945/ajcn.2009.28095 · DOI · Paper page
- Sezen AG . Prebiyotik, probiyotik ve sinbiyotiklerin insan ve hayvan sağlığı üzerine etkileri. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. 2013;8(3):248–258.
Cited by
Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041454 · Cited by 521
He, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289
“Gut microbiota and its metabolites cause insulin resistance and hyperinsulinemia by stimulating the secretion of gut-brain peptides and regulating inflammation pathway activation [24].”
BackgroundWang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162
Parker, J., O'Brien, C., & Hawrelak, J. (2022) · Obstetrics & Gynecology Science · doi:10.5468/ogs.21185 · Cited by 42
“These effects on human physiology and metabolism have been found to play a potential role in multiple diseases, including PCOS [10,12,13].”
BackgroundCalcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G. (2023) · Nutrients · doi:10.3390/nu15163582 · Cited by 27
Metadata
- Authors
- Yurtdaş, G., & Akdevelioğlu, Y.
- Venue
- Journal of the American College of Nutrition
- Publisher
- Informa UK Limited
- Published
- 2019-09-12
- Volume
- 39
- Issue
- 4
- Pages
- 371-382
- ISSN
- 0731-5724 (ISSN-L)
- 1541-1087
- OpenAlex
- W2972582268
- Cited by
- 153
- References
- 34
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota. https://app.cochat.ai/papers/10.1080/07315724.2019.1657515
- The paper
- Yurtdaş, G., & Akdevelioğlu, Y. (2020). A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota. Journal of the American College of Nutrition. https://doi.org/10.1080/07315724.2019.1657515
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.